Bionime Corporation (TPE:4737)
Taiwan · Delayed Price · Currency is TWD 61.70
+5.20 (9.20%)
At close: Mar 6, 2026
Bionime Market Cap
Bionime has a market cap or net worth of 4.15 billion as of March 6, 2026. Its market cap has increased by 2.74% in one year.
Market Cap
4.15B
Enterprise Value
6.76B
Revenue
1.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
61.70
Market Cap Chart
Since September 3, 2009, Bionime's market cap has increased from 2.06B to 4.15B, an increase of 101.19%. That is a compound annual growth rate of 4.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.15B | 3.70% |
| Dec 31, 2025 | 4.00B | 1.37% |
| Dec 31, 2024 | 3.95B | -13.19% |
| Dec 29, 2023 | 4.55B | -2.90% |
| Dec 30, 2022 | 4.69B | 2.61% |
| Dec 30, 2021 | 4.57B | 12.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medeon Biodesign | 7.75B |
| Formosa Optical Technology | 5.93B |
| Pacific Hospital Supply | 5.84B |
| St.Shine Optical | 5.55B |
| SciVision Biotech | 5.08B |
| Nang Kuang Pharmaceutical | 3.74B |
| Maxigen Biotech | 3.39B |
| ICARES Medicus | 3.28B |